FDA holds up Schering drug
114185
Shares drop as U.S. regulators say they want more info before approving caner medication Bonefos.
207285
Pfizer Inc. PFE.N has signed a deal  with Schering AG SCHG.DE granting it a worldwide license to  Schering's ADP receptor antagonist program, the U.S. drug maker  said on Wednesday.
454185
GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix, adding to pressure on the drug maker after controversy surrounding its diabetes drug Avandia.
457661
U.S. regulators need more clinical trials before they can approve heart-scan contrast agent MS-325 from Germany's Schering and U.S. partner Epix Pharmaceuticals, the companies said on Friday.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
725625
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
587421
Investors kept their eye on makers of generic pharmaceuticals Monday with news that Mylan Laboratories Inc. received Food and Drug Administration approval to market a generic version of a Novartis AG hypertension
565358
In the face of growing public distrust, the US Food and Drug Administration remains unpersuasive in claiming that its review of prescription drugs is sufficient or places the consumer first.
124030
Almost one-fifth of the Food and Drug Administration scientists surveyed two years ago as part of an official review said they had been pressured to recommend approval of a new drug despite
583937
BAYER has formed an alliance for its struggling pharmaceuticals business with American drug-maker Schering-Plough. Drugs and chemicals group Bayer, which is in the midst of restructuring its business, said
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
393883
Schering continues its strong sales and earnings growth.
287612
Pulling an application for Iressa from the EU makes the drug a has-been.
442828
Schering's hepatitis C drug works as well as Roche's.
273986
The US Food and Drug Administration (FDA) has issued final regulations on the establishment and maintenance of records to protect the US human food and animal feed supply in the event of credible threats of serious adverse health consequences or death to
274636
Merck and Schering-Plough get together again.
420195
Medarex's lead drug gets an important yet expected designation from the FDA.